Inducer for neural differentiation of mesenchymal stem cells
A differentiation inducer and mesenchymal stem cell technology, applied in the direction of cell culture active agent, animal cells, nervous system cells, etc., can solve the problems of cell transplantation tumorigenicity, high cell death rate, low induction efficiency, etc., and achieve induction differentiation efficiency High, broad clinical application prospects, short induction time effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0021] Example 1 The components of the inducer of the present invention are all commercially available products: acetaminophen, Shanghai Yiji Industrial Co., Ltd., article number Y903952; insulin, brand Sigma, article number 10908; GLP-1, brand Sigma, article number scp0153; Metinib, brand Meilun Bio, product number MB5401; Forskolin, brand Abcam, product number ab120058; KGF, brand Sigma, product number K1751; BMP-4, brand Sigma, product number SRP3016; human mesenchymal stem cell serum-free medium, brand LONZA, Item No. 00190632.
[0022] A mesenchymal stem cell neural differentiation inducer, which is composed of the following components, which are formulated according to the following mass concentration ratios: acetaminophen 5mg / L, insulin 5mg / L, GLP-14mg / L, trametinib 300μg / L, Forskolin 60 μg / L, KGF6 μg / L, BMP-46 μg / L. The above-mentioned components are sequentially added into human mesenchymal stem cell serum-free medium (or DMEM+10% FBS or other types of commercially ...
Embodiment 2
[0023] Example 2 An agent for inducing neural differentiation of mesenchymal stem cells, which is composed of the following components, which are formulated according to the following mass concentrations: acetaminophen 2mg / L, insulin 4mg / L, GLP-12mg / L, Qumei Tinib 200 μg / L, Forskolin 20 μg / L, KGF 2 μg / L, BMP-42 μg / L. The above-mentioned components are sequentially added into human mesenchymal stem cell serum-free medium (or DMEM+10% FBS or other types of commercially available mesenchymal stem cell medium) according to the mass concentration ratio, mixed evenly, and filtered to sterilize.
Embodiment 3
[0024] Example 3 An agent for inducing neural differentiation of mesenchymal stem cells, which is composed of the following components, which are formulated according to the following mass concentration ratios: acetaminophen 8 mg / L, insulin 6 mg / L, GLP-16 mg / L, Qumei Tinib 400 μg / L, Forskolin 100 μg / L, KGF 10 μg / L, BMP-4 10 μg / L. The above-mentioned components are sequentially added into human mesenchymal stem cell serum-free medium (or DMEM+10% FBS or other types of commercially available mesenchymal stem cell medium) according to the mass concentration ratio, mixed evenly, and filtered to sterilize.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com